236 related articles for article (PubMed ID: 33749155)
21. Impact of Maternal HIV Seroconversion during Pregnancy on Early Mother to Child Transmission of HIV (MTCT) Measured at 4-8 Weeks Postpartum in South Africa 2011-2012: A National Population-Based Evaluation.
Dinh TH; Delaney KP; Goga A; Jackson D; Lombard C; Woldesenbet S; Mogashoa M; Pillay Y; Shaffer N
PLoS One; 2015; 10(5):e0125525. PubMed ID: 25942423
[TBL] [Abstract][Full Text] [Related]
22. Protocol for the evaluation of the population-level impact of Zimbabwe's prevention of mother-to-child HIV transmission program option B+: a community based serial cross-sectional study.
Koyuncu A; Dufour MK; McCoy SI; Bautista-Arredondo S; Buzdugan R; Watadzaushe C; Dirawo J; Mushavi A; Mahomva A; Cowan F; Padian N
BMC Pregnancy Childbirth; 2019 Jan; 19(1):15. PubMed ID: 30621615
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of HIV-1 drug resistance amongst newly diagnosed HIV-infected infants age 4-8 weeks, enrolled in three nationally representative PMTCT effectiveness surveys, South Africa: 2010, 2011-12 and 2012-13.
Hunt GM; Ledwaba J; Salimo A; Kalimashe M; Dinh TH; Jackson D; Sherman G; Puren A; Ngandu NK; Lombard C; Morris L; Goga A
BMC Infect Dis; 2019 Sep; 19(Suppl 1):787. PubMed ID: 31526373
[TBL] [Abstract][Full Text] [Related]
24. Maternal Highly Active Antiretroviral Therapy and Child HIV-Free Survival in Malawi, 2004-2009.
Schwartz SR; Kumwenda N; Kumwenda J; Chen S; Mofenson LM; Taylor AW; Fowler MG; Taha TE
Matern Child Health J; 2016 Mar; 20(3):542-9. PubMed ID: 26525557
[TBL] [Abstract][Full Text] [Related]
25. Longitudinal adherence to maternal antiretroviral therapy and infant Nevirapine prophylaxis from 6 weeks to 18 months postpartum amongst a cohort of mothers and infants in South Africa.
Larsen A; Magasana V; Dinh TH; Ngandu N; Lombard C; Cheyip M; Ayalew K; Chirinda W; Kindra G; Jackson D; Goga A
BMC Infect Dis; 2019 Sep; 19(Suppl 1):789. PubMed ID: 31526366
[TBL] [Abstract][Full Text] [Related]
26. Use of data from various sources to evaluate and improve the prevention of mother-to-child transmission of HIV programme in Zimbabwe: a data integration exercise.
Sibanda EL; Webb K; Fahey CA; Kang Dufour MS; McCoy SI; Watadzaushe C; Dirawo J; Deda M; Chimwaza A; Taramusi I; Mushavi A; Mukungunugwa S; Padian N; Cowan FM
J Int AIDS Soc; 2020 Jun; 23 Suppl 3(Suppl 3):e25524. PubMed ID: 32602644
[TBL] [Abstract][Full Text] [Related]
27. Retention in care during the first 3 years of antiretroviral therapy for women in Malawi's option B+ programme: an observational cohort study.
Haas AD; Tenthani L; Msukwa MT; Tal K; Jahn A; Gadabu OJ; Spoerri A; Chimbwandira F; van Oosterhout JJ; Keiser O
Lancet HIV; 2016 Apr; 3(4):e175-82. PubMed ID: 27036993
[TBL] [Abstract][Full Text] [Related]
28. Investigation of mother-to-child transmission of HIV in pregnancy and among HIV-exposed infants accessing care at a PMTCT clinic in southwest Nigeria.
Afolabi AY; Bakarey AS; Kolawole OE; Kola OJ
J Immunoassay Immunochem; 2018; 39(4):403-415. PubMed ID: 30001188
[TBL] [Abstract][Full Text] [Related]
29. Prevention of mother-to-child transmission of HIV: a cross-sectional study in Malawi.
van Lettow M; Landes M; van Oosterhout JJ; Schouten E; Phiri H; Nkhoma E; Kalua T; Gupta S; Wadonda N; Jahn A; Tippett-Barr B
Bull World Health Organ; 2018 Apr; 96(4):256-265. PubMed ID: 29695882
[TBL] [Abstract][Full Text] [Related]
30. Optimizing HIV retesting during pregnancy and postpartum in four countries: a cost-effectiveness analysis.
Meisner J; Roberts DA; Rodriguez P; Sharma M; Newman Owiredu M; Gomez B; de Mello MB; Bobrik A; Vodianyk A; Storey A; Githuka G; Chidarikire T; Barnabas R; Farid S; Essajee S; Jamil MS; Baggaley R; Johnson C; Drake AL
J Int AIDS Soc; 2021 Apr; 24(4):e25686. PubMed ID: 33787064
[TBL] [Abstract][Full Text] [Related]
31. Same-day antiretroviral therapy (ART) initiation in pregnancy is not associated with viral suppression or engagement in care: A cohort study.
Langwenya N; Phillips TK; Brittain K; Zerbe A; Abrams EJ; Myer L
J Int AIDS Soc; 2018 Jun; 21(6):e25133. PubMed ID: 29939483
[TBL] [Abstract][Full Text] [Related]
32. Supporting Option B+ scale up and strengthening the prevention of mother-to-child transmission cascade in central Malawi: results from a serial cross-sectional study.
Herce ME; Mtande T; Chimbwandira F; Mofolo I; Chingondole CK; Rosenberg NE; Lancaster KE; Kamanga E; Chinkonde J; Kumwenda W; Tegha G; Hosseinipour MC; Hoffman IF; Martinson FE; Stein E; van der Horst CM
BMC Infect Dis; 2015 Aug; 15():328. PubMed ID: 26265222
[TBL] [Abstract][Full Text] [Related]
33. HIV viraemia and mother-to-child transmission risk after antiretroviral therapy initiation in pregnancy in Cape Town, South Africa.
Myer L; Phillips TK; McIntyre JA; Hsiao NY; Petro G; Zerbe A; Ramjith J; Bekker LG; Abrams EJ
HIV Med; 2017 Feb; 18(2):80-88. PubMed ID: 27353189
[TBL] [Abstract][Full Text] [Related]
34. Modeling the Impact of Retention Interventions on Mother-to-Child Transmission of HIV: Results From INSPIRE Studies in Malawi, Nigeria, and Zimbabwe.
McCarthy E; Joseph J; Foster G; Mangwiro AZ; Mwapasa V; Oyeledun B; Phiri S; Sam-Agudu NA; Essajee S
J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2(2):S233-S239. PubMed ID: 28498194
[TBL] [Abstract][Full Text] [Related]
35. Retest and treat: a review of national HIV retesting guidelines to inform elimination of mother-to-child HIV transmission (EMTCT) efforts.
Drake AL; Thomson KA; Quinn C; Newman Owiredu M; Nuwagira IB; Chitembo L; Essajee S; Baggaley R; Johnson CC
J Int AIDS Soc; 2019 Apr; 22(4):e25271. PubMed ID: 30958644
[TBL] [Abstract][Full Text] [Related]
36. Maternal Humoral Immune Responses Do Not Predict Postnatal HIV-1 Transmission Risk in Antiretroviral-Treated Mothers from the IMPAACT PROMISE Study.
Hompe ED; Jacobson DL; Eudailey JA; Butler K; Edwards W; Pollara J; Brummel SS; Fouda GG; Chinula L; Kamanga M; Kinikar A; Moodley D; Owor M; Fowler MG; Permar SR
mSphere; 2019 Oct; 4(5):. PubMed ID: 31645430
[TBL] [Abstract][Full Text] [Related]
37. Receipt of infant HIV DNA PCR test results is associated with a reduction in retention of HIV-exposed infants in integrated HIV care and healthcare services: a quantitative sub-study nested within a cluster randomised trial in rural Malawi.
Milanzi E; Mwapasa V; Joseph J; Jousset A; Tchereni T; Gunda A; Phiri J; Reece JC
BMC Public Health; 2020 Dec; 20(1):1879. PubMed ID: 33287772
[TBL] [Abstract][Full Text] [Related]
38. Prevention of mother-to-child transmission of HIV in rural Uganda: modelling effectiveness and impact of scaling-up PMTCT services.
Larsson EC; Ekström AM; Pariyo G; Tomson G; Sarowar M; Baluka R; Galiwango E; Thorson AE
Glob Health Action; 2015; 8():26308. PubMed ID: 25726836
[TBL] [Abstract][Full Text] [Related]
39. Determinants of HIV infection among children born to mothers on prevention of mother to child transmission program of HIV in Addis Ababa, Ethiopia: a case control study.
Beyene GA; Dadi LS; Mogas SB
BMC Infect Dis; 2018 Jul; 18(1):327. PubMed ID: 30005617
[TBL] [Abstract][Full Text] [Related]
40. Comparative cost-effectiveness of Option B+ for prevention of mother-to-child transmission of HIV in Malawi.
Tweya H; Keiser O; Haas AD; Tenthani L; Phiri S; Egger M; Estill J
AIDS; 2016 Mar; 30(6):953-62. PubMed ID: 26691682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
